A middle-aged womanwith lupus cystitis showedno other symptomsof lupus vasculitis. Cystoscopic findings revealed mucosal hemorrhage and hyperemia. Histological studies of the bladder showed mucosal edema, inflammatory cellular infiltration and the deposition of immune complexes along the vessels. She was treated with a combination of intravenous methylprednisolone pulse therapy and oral prednisolone.
Introduction
Bladder injury is a rare complication in systemic lupus erythematosus (SLE) (1) (2) (3) (4) . The incidence of lupus cystitis, caused by immune complex-mediated vasculitis, is reported to be 1-2% of SLE (1) . Lupus cystitis is frequently accompanied by lupus enteritis and/or central nervous system (CNS) lupus and shows poor prognosis in spite of various immunesuppressive therapies. Wedescribe here a patient with lupus cystitis whoshowedno other systemic involvement of vasculitis; she was efficiently treated with a combination of methylprednisolone pulse therapy and oral prednisolone therapy. This suggests that high-dose steroid therapy is effective in such lupus cystitis patients.
Case Report
In July 1 989, a45-year-old womanwas admitted to Kanazawa University Hospital because of pollakisuria, dry mouth, dry eye, arthralgia and Raynaud' s phenomenon. From March 1 985, she had suffered from pollakisuria which is resistant to various types of antibiotics. Physical examination revealed the swelling of bilateral parotid glands and sausage-like fingers. Urine analysis showed proteinuria of 0.70 g/day and no microscopic hematuria. The urine sediment showed somegranular casts. Urine culture and cytology were negative. Hematological laboratory test results were hematocrit 26.2% , red blood count 308,000/mm3 and hemoglobin 8.7 g/dl. Renal function was normal. Serological testing was positive for direct Coombs ' test. Erythrocyte sedimentation rate (ESR) was 157 mm/h. Antinuclear antibody (ANA)titer was x 1 0,240 (homogeneous, speckled pattern) and antibody to double-stranded DNA(dsDNAAb) was 542 U/ml. Lupus erythematosus (LE) test and anti SS-A antibody were positive, however, anti ribonucleoprotein (RNP) antibody was negative. CH50 and components of complement were decreased (CH50 25 U/ml, C3c 33 mg/dl, C4 1 2 mg/dl). There was remarkable hypergammaglobulinemia (IgG 6,638 mg/dl, IgA 477 mg/dl, IgM 187 mg/dl). Amylase was increased to 673 U// and salivary component was dominant.
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SLE was diagnosed on the 1982 criteria of the American Rheumatoid Association. A renal biopsy showed pure mesangial alteration (World Health Organization, WHOclass II). There were no findings of CNSlupus and lupus enteritis. In addition, a diagnosis of Sjogren's syndrome (SjS) was made with conjunctivitis with positive Schirmer and rose bengal tests, and defects in salivary glands on 99mTcO4~scan. Moreover, progressive systemic sclerosis (PSS) was diagnosed from sausagelike fingers and histological findings of arm skin biopsy. Taken together, the diagnosis of overlap syndrome was made. The cystoscopic examination revealed hyperemia and patches of hemorrhages in the mucosa of the bladder. A bladder biopsy showed edema of the mucosa, predominant infiltration of plasma cells and mononuclear lymphocytes in the interstinum, and deposition of acidophilic substance along the blood vessel walls with lymphocyte infiltration (Fig. la, b) . The immunofluorescence microscopic findings revealed granular deposition of immune complex containing IgG, C3, Clq, C5 and C9 along the blood vessel walls (Fig. lc) . Accordingly, we made the diagnosis of lupus cystitis due to immunecomplex-mediated vasculitis.
Methylprednisolone pulse therapy (1,000 mg/day, 3 days) was performed five times accompanied by oral daily prednisolone 20 mg (Fig. 2) . These treatments provided both the improvement of serological data and clinical symptoms. After the therapy, cystoscopic examination and bladder biopsy showed excellent improvement. Wemeasured the urinary levels of chemokines, interleukin-8 (IL-8) and monocyte chemotactic and activating factor (MCAF) by ELISA, which are involved in both the recruitment and activation ofneutrophils and monocytes respectively (5). Elevated urinary IL-8 level (29.7 pg/ml, detection limitin this ELISA, <16pg/ml) and MCAFlevel (178.0pg/ ml, detection limit in this ELISA, <40 pg/ml) decreased during steroid pulse therapy-induced convalescence (<16 pg/ml, 84.0 pg/ml, respectively). She had received daily prednisolone 10 mgfor maintenance, but again suffered from pollakisuria concomitant with elevation of the titer of ds-DNAAb three years later. Steroid pulse therapy was performed three more times, and her symptoms were improved (Fig. 2) . She has been receiving daily prednisolone 20 mgfor maintenance and her symptoms havenever recurred.
Discussion
In 1938, Fister first reported a patient of SLE accompanied with interstitial cystitis (6) . The exact etiology of lupus cystitis is unknown.Bladder biopsies of lupus cystitis showgranular deposits of immune complex (IgG, IgA, IgM and C3, Clq) with mononuclear and polymorphonuclear leukocytes along blood vessel walls, as was also shown in our patient (7) (8) (9) . These findings suggest that immunecomplex-mediated vasculitis is one of the attributable causes of lupus cystitis (5, 7) . Antibladder antibody and anti-intermediate filament antibody have been detected and these antibodies might cause lupus cystitis in some cases (8) . On the otherhand, both SjS andPSShave never been reported to be accompanied by immunecomplex-mediated vasculitis; and in the present case, these complications showed only subclinical symptoms. Lupus cystitis is often accompanied with lupus enteritis and/or CNSlupus, but the exact mechanisms remain unclear (1-4, 7, 10-14) . Bowel involvement of SLE is generally thought to be due to either mesenteric arteritis or sterile serotitis and the deposition of immunecomplex or the infiltration of lymphocytes around blood vessel walls have been observed in some cases (1, 3, 1 1) . The mechanism of CNSlupus is varied and difficult to confirm because of rare autopsy chance, but vasculitis is considered as one of the most important causes based on brain scan findings on magnetic resonance imaging (15). Taken altogether, lupus cystitis, including our case, can be regarded as a sign of a widespread vasculitis (10, 1 1, 16).
The onset of lupus cystitis in the present case remains unclear. There are somereports about cases whose cystitis preceded other symptomsof SLEby several years as in the present case (1, 4) . In addition, our case had neither lupus enteropathy nor CNS lupus and showed good responses to therapy. Moreover, lupus cystitis patients with other vasculitic symptoms show poor responses to therapy (1, 3, 4, 10) . These results suggested that a precise and early diagnosis of lupus cystitis should be madewhenseeing patients with symptoms like cystitis. As for the treatment oflupus cystitis , corticosteroids and immunosuppressive drugs are used and improve the prognosis oflupus cystitis (1, 7-9, 1 1, 13, 17) . In previous reports, patients with earlier diagnoses achieved improvement of symptoms oflupus cystitis by daily oral 40 to 120 mg ofprednisolone (1, 7, 9, ll, 13) . In the present case, we administered intravenous methylprednisolone pulse therapy 5 times ( 1 ,000 mg daily for three days) as well as daily prednisolone 20 mg and achieved good response from cystitis symptoms. Four lupus cystitis patients treated with methylprednisolone pulse therapy have been previously reported (1, 4, 10, 1 1) . The patient with fewer complications of vasculitis showeda better response to methylprednisolone pulse therapy (1 1). In our case, multiple methylprednisolone pulse therapies were necessary to treat cystic vasculitis, because the cystitis symptoms could not be improved by the typical oral prednisolone therapy and there was partial relapse after each methylprednisolone pulse therapy. These results suggested that early and appropriate treatment, as well as an exact and early diagnosis, in addition to methylprednisolone pulse therapy maybe important in achieving an improvement of lupus cystitis.
Clinical improvement of lupus cystitis by high doses of intravenous methylprednisolone was noted in patients without other systemic involvement of vasculitis (1 1). However, the precise mechanismof the effects of corticosteroid remains unclear. In lupus nephritis, the aberrant expression ofHLA-DQ antigen in glomeruli and various cytokines, such as y-IFN are related to the activity of lupus nephritis (18). Moreover, the abnormal cytokine production and intraglomerular cellular activation could be improved by methylprednisolone pulse therapy (5) . The involvement of various cytokines in lupus cystitis is not clear. However, we observed cellular infiltration around the vessels and pathological resolution of infiltrated cells concomitant with disease activities associated with the resolution of elevated levels of urinary chemokines, IL-8 and MCAF.These results suggested that similar mechanisms of abnormal cytokine production and cellular activation in the bladder might play an important role in immune-mediated lupus cystitis and that the pulse therapy mayinduce clinical and pathological resolution by suppressing the excess cytokine production from activated T lymphocytes and monocytes and activated cells in the bladder.
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